{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T21:41:15Z","timestamp":1682286075569},"reference-count":16,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1006\/biol.2001.0303","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T18:54:13Z","timestamp":1033930453000},"page":"237-242","source":"Crossref","is-referenced-by-count":4,"title":["Peptide-based Synthetic Recombinant Vaccines with Anti-viral Efficacy"],"prefix":"10.1006","volume":"29","author":[{"given":"R.","family":"Arnon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Tarrab-Hazdai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ben-Yedidia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/biol.2001.0303_RF1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000237175","article-title":"Synthetic recombinant vaccines against viral agents","volume":"108","author":"Arnon","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1006\/biol.2001.0303_RF2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0958-1669(97)80066-3","article-title":"Design of peptide and polypeptide vaccines","volume":"8","author":"Ben-Yedidia","year":"1997","journal-title":"Curr Opin Biotech"},{"key":"10.1006\/biol.2001.0303_RF3","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1002\/j.1460-2075.1985.tb04086.x","article-title":"Priming immunization against cholera toxin and E. coli heat labile toxin by cholera toxin short peptide \u03b2 hybrid in E. coli","volume":"4","author":"Jacob","year":"1985","journal-title":"EMBO J"},{"key":"10.1006\/biol.2001.0303_RF4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/330381a0","article-title":"Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein","volume":"330","author":"Clarke","year":"1987","journal-title":"Nature"},{"key":"10.1006\/biol.2001.0303_RF5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0264-410X(91)90248-5","article-title":"Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted","volume":"9","author":"Brown","year":"1991","journal-title":"Vaccine"},{"key":"10.1006\/biol.2001.0303_RF6","first-page":"35","article-title":"Vaccinia virus: a novel approach for molecular engineering of peptide vaccines","volume":"30","author":"Hruby","year":"1993","journal-title":"Semin Haematol"},{"key":"10.1006\/biol.2001.0303_RF7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1099\/0022-1317-79-1-83","article-title":"Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice","volume":"79","author":"Hanke","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1006\/biol.2001.0303_RF8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1146\/annurev.iy.08.040190.003513","article-title":"Structural basis of immune recognition of influenza virus haemagglutinin","volume":"8","author":"Wilson","year":"1990","journal-title":"Annu Rev Immunol"},{"key":"10.1006\/biol.2001.0303_RF9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0008-8749(79)90178-3","article-title":"Role of T-cell function in recovery from murine influenza infection","volume":"43","author":"Yap","year":"1979","journal-title":"Cell Immunol"},{"key":"10.1006\/biol.2001.0303_RF10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.2468182","article-title":"Immune response to cholera toxin epitope inserted in Salmonella flagellin expression and live-vaccine potential","volume":"244","author":"Newton","year":"1989","journal-title":"Science"},{"key":"10.1006\/biol.2001.0303_RF11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0264-410X(95)00088-I","article-title":"Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection","volume":"14","author":"Levi","year":"1996","journal-title":"Vaccine"},{"key":"10.1006\/biol.2001.0303_RF12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0047-6374(98)00045-1","article-title":"Efficacy of anti-influenza peptide vaccine in aged mice","volume":"104","author":"Ben-Yedidia","year":"1998","journal-title":"Mechanism of ageing and development"},{"key":"10.1006\/biol.2001.0303_RF13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0167-7799(98)01203-7","article-title":"The trimera mouse: generating human monoclonal antibodies and an animal model for human diseases","volume":"16","author":"Reisner","year":"1998","journal-title":"Trends Biotech"},{"key":"10.1006\/biol.2001.0303_RF14","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/intimm\/11.7.1043","article-title":"Intranasal administration of peptide based vaccine protects human\/mouse radiation chimaera from influenza infection","volume":"11","author":"Ben-Yedidia","year":"1999","journal-title":"Intern Immunol"},{"key":"10.1006\/biol.2001.0303_RF15","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.4049\/jimmunol.135.4.2772","article-title":"Protective monoclonal antibodies against Schistosoma mansoni. Antigen isolation, characterization and suitability for active immunization","volume":"135","author":"Tarrab-Hazdai","year":"1985","journal-title":"J Immunol"},{"key":"10.1006\/biol.2001.0303_RF16","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1128\/IAI.67.9.4360-4366.1999","article-title":"Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni","volume":"67","author":"Ben-Yedidia","year":"1999","journal-title":"Infect Immun"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105601903033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105601903033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T21:02:04Z","timestamp":1682283724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105601903033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":16,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["S1045105601903033"],"URL":"https:\/\/doi.org\/10.1006\/biol.2001.0303","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}